In genetically engineered mouse models, the WDR4/Promyelocytic leukemia (PML) axis elevates intratumoral Tregs and M2-like macrophages and reduces CD8+ T cells to promote lung tumor growth. The gene discussed is CD8A; the disease is leukemia.